This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JOHN T. PHELAN, MD; JUAN JUARDO, MD

AMA Arch Surg. 1963;87(2):212-214.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Superficial basal cell carcinomas of the chin and cheek are currently treated by electrical and chemical dissection, surgical excision, and radiation therapy. Each of these methods has proved its usefulness in the management of basal cell carcinoma; however, each has certain limitations as attested by the number of reports that have been published concerning the management of recurrent lesions. In our opinion, the principal factor responsible for the recurrence of a basal cell carcinoma is the failure of the initial method of therapy to totally eradicate the tumor. Because of this problem, we began in 1960 to treat a selected group of basal cell carcinomas of the face by Mohs' chemosurgery technique,¹ as it was our belief that this method offered certain advantages of insuring total tumor removal that were not apparent in the more conventional forms of therapy.

Because collective experience with Mohs' chemosurgery technique is limited, it . . . [Full Text PDF of this Article]

Author Affiliations
BUFFALO

Departments of Surgery and Pathology, Roswell Park Memorial Institute, New York State Department of Health.

Footnotes
Submitted for publication Jan. 2, 1963.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?